Share >  
Share
Share on Tumblr

Emcure Pharmaceuticals

News »

   latest by relevance
Chasing cheaper cancer drugs
Apr 02, 2012 at 09:46 | Source: Reuters
In a nondescript suburb south of London, tucked away behind a big hospital, Paul Workman and fellow scientists are celebrating victory in the "World Cup" of cancer drug research for their work in discovering a stream of new medicines.
Roche to sell cheaper cancer drugs in India
Mar 23, 2012 at 11:56 | Source: Reuters
Roche Holding AG will launch two locally branded cancer drugs in India at "significantly lower" prices by the end of this year or early next year, a Roche spokesman said on Friday.
No Borrower, No Lender, Yet Willful Defaulter?
Sep 17, 2011 at 11:16 | Source: Moneycontrol.com
Who is a Willful Defaulter? The answer to that question lies in one judgment covering two cases and setting a precedent for all derivatives transactions. Payaswini Upadhyay has the details.
Emcure Pharma plans Rs 700 crore IPO
Apr 08, 2011 at 10:18 | Source: Business Line
Pune-based manufacturer of drugs, Emcure Pharmaceuticals, is planning to raise money through an initial public offering, according to market sources. The size of the IPO, expected to come in the second half of the year, is around Rs 650-700 crore.
India-Brazil poised for cooperation in pharma & healthcare
Aug 12, 2008 at 13:42
India-Brazil poised for Greater Cooperation in Pharma & Healthcare
TAKE Sols PharmaReady bags 4 new Indian clients this qtr
Jul 23, 2008 at 18:50
TAKE Solutions announced today that its worldwide business in regulatory document management and electronic submissions software arena is making quick inroads in the Indian market.

Videos »
No Borrower, No Lender, Yet Willful Defaulter?
more »

Photos »

  /  
News across the web »
Pill Talk
Ainapur, an arid village near the district town of Gulbarga in north-eastern Karnataka, seems an unlikely location to discuss pharmaceutical research, or the pricing strategy of the big pharma compan...
Mar 28, 2012 at 11:08 | Source: Business Today
Roche to sell cheaper cancer drugs in IndiaThe world's biggest cancer drugs maker to offer locally branded versions of Herception, MabThera by early next year
Swiss drug maker Roche Holding AG plans to offer cut-price versions of two blockbuster cancer drugs for the Indian market soon, a company spokesman said on Friday, days after the government moved to s...
Mar 24, 2012 at 03:26 | Source: Business Standard
Roche to slash prices of cancer drugs in India
New York, March 23: Global pharma major Roche is all set to slash the price of two expensive cancer drugs in India, as part of efforts to strengthen its position amid rising competition from generic ...
Mar 23, 2012 at 21:23 | Source: The Hindu BusinessLine
Roche to cut prices of two cancer drugs in India: Report
MUMBAI: Swiss drugmaker Roche Holding AG plans to offer cut-price versions of two blockbuster cancer drugs for the Indian market soon, a company spokesman said on Friday, days after New Delhi moved t...
Mar 23, 2012 at 13:28 | Source: Economic Times
MNCs circle, descend on Indian vaccine marketIntroduction of immunisation programme and aggressive product rollout by domestic firms are prompting MNCs to strengthen presence
Global majors are trying to get into the high-growth vaccine market in India through standalone launches and alliances with local partners. Introduction of the National Immunisation Programme (NIP) an...
Mar 11, 2012 at 02:07 | Source: Business Standard
more »
Interact & exchange stock tips & market info »

Web Messenger

Platinum Member

108154 Followers

News Now  

Drug-maker Sanofi`s vaccines division Sanofi Pasteur has formalised a ...

1.10 PM Feb 19th

Related News »
Indian API players file 404 Drug Master Files in 2011 with US FDA
Hetro Group, based in Hyderabad, consisting of Hetero Drugs Ltd and Hetero Labs Ltd, submitted 42 DMFs in US followed by Dr Reddy's Laboratories with 20 DMFs, Alembic Pharmaceuticals 17 DMFs and Emcure Pharmaceuticals Ltd 14 DMFs, Jubilant Life Sciences ...
May 21, 2012 at 02:25 | Source: pharmabiz.com
Compulsory licensing sets off a wave of price cuts in cancer drugs
Roche has decided to reintroduce its Herceptin (trastuzumab) and MabThera (rituximab) drugs in India under new names and lower prices by outsourcing their manufacturing to local drug maker Emcure Pharmaceuticals Ltd. Herceptin and MabThera are currently ...
May 8, 2012 at 18:04 | Source: Livemint.com

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window